Recent Research Analysts’ Ratings Updates for Edwards Lifesciences (EW)

Several brokerages have updated their recommendations and price targets on shares of Edwards Lifesciences (NYSE: EW) in the last few weeks: 12/16/2024 – Edwards Lifesciences was upgraded by analysts at Bank of America Co. from a “neutral” rating to a “buy” rating. They now have a $90.00 price target on the stock, up previously from […]

Leave a Reply

Your email address will not be published.

Previous post Reliance Global Group Reflects on Strategic Achievements in Year-End Review – Eyes on Future Growth
Next post Colabor Group (TSE:GCL) Hits New 12-Month Low – Time to Sell?